Patent details

Basic Information

Publication number:

92782

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP047265905

Legal Status:

Active

Application number:

92782

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/14/984 - Xadago - safinamide

Marketing Authorization Type:

Marketing Authorization Date:

24/02/2015

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Dates

Filing date:

22/07/2015

First Marketing Authorization date:

24/02/2015

Grant date:

22/09/2015

Activation date:

08/04/2024

Publication date:

22/09/2015

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

08/04/2029

SPC Extension Expiration:

08/04/2029

Rejection date:

Withdrawal date:

Owner

From:

10/04/2020

 

 

Name:

Newron Pharmaceuticals S.p.A.

Address:

Via Antonio Meucci 3, 20091, Bresso, Italy (IT)

History of Owners

From:

22/07/2015

To:

10/04/2020

Name:

Newron Pharmaceuticals S.p.A.

Address:

Via L. Ariosto, 21, 20091 Bresso (MI), Italy (IT)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

22/07/2015

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

BENATTI Luca

Address:

Italy (IT)

2

Name:

RUGGERO Fariello

Address:

Italy (IT)

3

Name:

SALVATI Patricia

Address:

Italy (IT)

4

Name:

CATTANEO Carlo

Address:

Italy (IT)

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2020/06

Publication date:

07/05/2020

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

SPC3

Bulletin edition number:

2025/04

Publication date:

04/03/2025

Description:

Section E : Supplementary Protection certificates entered into force – IA publication

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20200000111A

Date Registered:

10/04/2020

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

changement d'adresse

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Newron Pharmaceuticals S.p.A.

Address:

Via Antonio Meucci 3, 20091, Bresso, Italy (IT)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

30/04/2027

Annual Fee Number:

24

Annual Fee Amount:

440 Euro

Expected Payer:

Last Annual Fee Payment Date:

17/03/2026

Last Annual Fee Paid Number:

23

Last Annual Fee Paid Amount:

430 Euro

Payer:

Computer Packages INC

Filing date	Document type	Number of pages
10/04/2020	Request For Change	1
10/04/2020	Outgoing Correspondence	1